| Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer M Arechederra, F Daian, A Yim, SK Bazai, S Richelme, R Dono, AJ Saurin, ... Nature communications 9 (1), 3164, 2018 | 177 | 2018 |
| p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway Á Gutiérrez-Uzquiza, M Arechederra, P Bragado, JA Aguirre-Ghiso, ... Journal of Biological Chemistry 287 (4), 2632-2642, 2012 | 153 | 2012 |
| Chronic hepatitis B in pregnancy: unique challenges and opportunities K Yogeswaran, SK Fung The Korean journal of hepatology 17 (1), 1, 2011 | 84 | 2011 |
| Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg MG Fernández-Barrena, M Arechederra, L Colyn, C Berasain, MA Avila Jhep Reports 2 (6), 100167, 2020 | 76 | 2020 |
| Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis M Barcena-Varela, H Paish, L Alvarez, I Uriarte, MU Latasa, E Santamaria, ... Gut 70 (2), 388-400, 2021 | 70 | 2021 |
| Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins M Jiménez, R Urtasun, M Elizalde, M Azkona, MU Latasa, I Uriarte, ... Nucleic acids research 47 (7), 3450-3466, 2019 | 56 | 2019 |
| Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach JM Urman, JM Herranz, I Uriarte, M Rullán, D Oyón, B González, ... Cancers 12 (6), 1644, 2020 | 44 | 2020 |
| Met signaling in cardiomyocytes is required for normal cardiac function in adult mice M Arechederra, R Carmona, M González-Nuñez, Á Gutiérrez-Uzquiza, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (12 …, 2013 | 44 | 2013 |
| C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: involvement in cell death Á Gutiérrez-Uzquiza, M Arechederra, I Molina, R Baños, V Maia, M Benito, ... Cellular signalling 22 (3), 533-542, 2010 | 43 | 2010 |
| ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma M Arechederra, SK Bazai, A Abdouni, C Sequera, TJ Mead, S Richelme, ... Journal of Hepatology 74 (4), 893-906, 2021 | 39 | 2021 |
| Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine M Arechederra, MA Ávila, C Berasain Advances in Laboratory Medicine/Avances en Medicina de Laboratorio 1 (3 …, 2020 | 36 | 2020 |
| Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures M Arechederra, M Rullán, I Amat, D Oyon, L Zabalza, M Elizalde, ... Gut 71 (6), 1141-1151, 2022 | 35 | 2022 |
| C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms N Priego, M Arechederra, C Sequera, P Bragado, A Vázquez-Carballo, ... Oncotarget 7 (29), 45060, 2016 | 34 | 2016 |
| Dual targeting of G9a and DNA methyltransferase‐1 for the treatment of experimental cholangiocarcinoma L Colyn, M Bárcena‐Varela, G Álvarez‐Sola, MU Latasa, I Uriarte, ... Hepatology 73 (6), 2380-2396, 2021 | 33 | 2021 |
| p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion M Arechederra, N Priego, A Vázquez-Carballo, C Sequera, ... Journal of Biological Chemistry 290 (7), 4383-4397, 2015 | 32 | 2015 |
| Loss of liver function in chronic liver disease: An identity crisis C Berasain, M Arechederra, J Argemí, MG Fernández-Barrena, MA Avila Journal of hepatology 78 (2), 401-414, 2023 | 31 | 2023 |
| Epigenetics in liver fibrosis: could HDACs be a therapeutic target? A Claveria-Cabello, L Colyn, M Arechederra, JM Urman, C Berasain, ... Cells 9 (10), 2321, 2020 | 30 | 2020 |
| Epigenetic mechanisms in gastric cancer: potential new therapeutic opportunities M Canale, A Casadei-Gardini, P Ulivi, M Arechederra, C Berasain, ... International Journal of Molecular Sciences 21 (15), 5500, 2020 | 30 | 2020 |
| Epigenetic biomarkers for the diagnosis and treatment of liver disease M Arechederra, M Recalde, M Gárate-Rascón, MG Fernández-Barrena, ... Cancers 13 (6), 1265, 2021 | 27 | 2021 |
| A phosphokinome‐based screen uncovers new drug synergies for cancer driven by liver‐specific gain of nononcogenic receptor tyrosine kinases Y Fan, M Arechederra, S Richelme, F Daian, C Novello, J Calderaro, ... Hepatology 66 (5), 1644-1661, 2017 | 22 | 2017 |
Flavio MainaGroup Leader, IBDM, CNRS UMR 7288, Aix Marseille UniversityVerified email at univ-amu.fr
